MODERATOR(S)
Evan Osmundson, MD, PhD - Vanderbilt-Ingram Cancer Center
Gregory Videtic, MD, CM, FRCPC, FACR, FASTRO - Cleveland Clinic
session DESCRIPTION
Quick Pitch sessions provide opportunities for presenters to summarize outcomes while highlighting key takeaways from their research in a fast-paced format to present concise takeaways.
Credits
| AMA PRA Category 1 Credits: | 1.00 |
| CAMPEP Credits: | 1.00 |
| MDCB Credits: | 1.00 |
Presentations
-
05:00pm - 05:20pm ETSpeaker: Evan Osmundson, MD, PhD - Vanderbilt-Ingram Cancer Center, Nashville
-
05:20pm - 05:25pm ET
Phase 1 Trial of CT-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for Treatment of Ultra-Central Early-Stage Non-Small Cell Lung Cancer (NSCLC)
Speaker: Alden D'Souza, MD, MPHS - Washington University in St. Louis School of Medicine, St Louis -
05:25pm - 05:30pm ET
Prospective Study of Surface Guided Radiation Therapy (SGRT) Alone or in Combination with Fiducials for Free Breathing (FB) vs. Breath Hold (BH) Stereotactic Body Radiation Therapy (SBRT) Treatments of the Lung
Speaker: John Heinzerling, MD - Atrium Health Levine Cancer, Wake Forest School of Medicine, Southeast Radiation Oncology Group PA, Charlotte -
05:30pm - 05:35pm ET
Adebrelimab as Maintenance Therapy Following Hyperfractionated Simultaneous Integrated Boost Radiotherapy Plus Chemotherapy in Limited-Stage Small-Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Phase II Trial
Speaker: Jiayi Yu, MD, PhD - Peking University Cancer Hospital and Institute, Beijing -
05:35pm - 05:40pm ET
Optimizing Nodal Target Delineation in Limited-Stage Small Cell Lung Cancer: A Large-Scale, Multi-Institutional Study
Speaker: Xiaolong Wang, MS - Shandong Cancer Hospital and Institute, jinan -
05:40pm - 05:45pm ET
Induction Immunochemotherapy followed by Definitive Radiotherapy in Patients with Limited-Stage Small Cell Lung Cancer: A Multicenter Study
Speaker: Junxu Wen, MS - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan -
05:45pm - 05:50pm ET
Safety and Outcomes of Lung SBRT in Severely Pulmonary Impaired Patients with FEV1 or DLCO =25% Predicted
Speaker: Katherine Amarell, MD, BS - Cleveland Clinic Foundation, Cleveland -
05:50pm - 05:55pm ETSpeaker: Gregory Videtic, MD, CM, FRCPC, FACR, FASTRO - Cleveland Clinic, Cleveland Heights
-
05:55pm - 06:00pm ETSpeaker: Gregory Videtic, MD, CM, FRCPC, FACR, FASTRO - Cleveland Clinic, Cleveland Heights